Measurement of 5-HIAA levels in ventricular CSF (by LCEC) and in striatum (by in vivo voltammetry) during pharmacological modifications of serotonin metabolism in the rat.
The relationship between the concentrations of 5-hydroxyindoleacetic acid (5-HIAA) in the CSF and in the striatum has been evaluated in the rat by measuring the levels of this metabolite in ventricular CSF (by liquid chromatography coupled with electrochemical detection) and in the striatal extracellular fluid (by in vivo voltammetry) after administration of inhibitors of serotonin synthesis or degradation. Pargyline, NSD 1015 and alpha-propyldopacetamide all caused an exponential decline of 5-HIAA in both CSF and striatum. For a given drug, the rate constants for 5-HIAA disappearance were identical in the CSF and in the striatal extracellular fluid. These results confirm the view that CSF 5-HIAA may serve as a good index of brain serotonin turnover.
Mignot
E
E
Serrano
A
A
Laude
D
D
Elghozi
J L
JL
Dedek
J
J
Scatton
B
B
D000577:Amides / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000032:analysis*; D004563:Electrochemistry; D006834:Hydrazines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000032:analysis* / Q000134:cerebrospinal fluid; D008297:Male; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D000577:Amides; D006834:Hydrazines; C100072:dihydroxyphenylvaleramide; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D010293:Pargyline; C004297:3-hydroxybenzylhydrazine